Page 36 - Read Online
P. 36

Page 14 of 15                                        Kumar et al. Mini-invasive Surg 2018;2:19  I  http://dx.doi.org/10.20517/2574-1225.2018.26

               49.  Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Results of
                   a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant
                   disease? Ann Surg 2012;255:1129-34.
               50.  Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishihara S, Ishiguro M,
                   Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Boku N, Fujimori T, Koinuma N,
                   Morita T, Nishimura G, Sakata Y, Takahashi K, Tsuruta O. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines
                   2014 for treatment of colorectal cancer. Int J Clin Oncol 2015;20:207-39.
               51.  Moran B. Exploring the limits in low rectal cancer. Lancet Oncol 2012;13:565-7.
               52.  Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M,
                   Yamaguchi T, Watanabe T, Muto T. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated
                   with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 2014;21:189-96.
               53.  Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T. Randomized, controlled trial of lateral node dissection
                   vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001;44:1274-80.
               54.  Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y; Colorectal
                   Cancer Study Group of Japan Clinical Oncology Group. Postoperative morbidity and mortality after mesorectal excision with and
                   without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre,
                   randomised controlled, non-inferiority trial. Lancet Oncol 2012;13:616-21.
               55.  Gk K, Vd P, Ap S. Is there a role of lateral pelvic lymph node dissection in the current era of neoadjuvant chemoradiotherapy for rectal
                   cancer? J Gastrointest Digest Syst 2016;6:1-4.
               56.  Mahendra BK, Vallam KC, Saklani A. Lateral pelvic lymph node dissection - are we ready to bridge the gap between the west and the
                   east? Ann Laparosc Endosc Surg 2017;2:158.
               57.  Sasi S, Rohila J, Kammar P, Kurunkar S, Desouza A, Saklani A. Robotic lateral pelvic lymph node dissection (LPLND) in rectal cancer
                   - video vignette. Colorectal Dis 2018;20:554-5.
               58.  Liang JT. Technical feasibility of laparoscopic lateral pelvic lymph node dissection for patients with low rectal cancer after concurrent
                   chemoradiation therapy. Ann Surg Oncol 2011;18:153-9.
               59.  Park JS, Choi GS, Lim KH, Jang YS, Kim HJ, Park SY, Jun SH. Laparoscopic extended lateral pelvic node dissection following total
                   mesorectal excision for advanced rectal cancer: initial clinical experience. Surg Endosc 2011;25:3322-9.
               60.  Liu T, Zhang C, Yu P, Chen J, Zeng D, Gan L, Lv W, Liu L, Yan X. Laparoscopic radical correction combined with extensive
                   lymphadenectomy and pelvic autonomic nerve preservation for mid-to-low rectal cancer. Clin Colorectal Cancer 2011;10:183-7.
               61.  Akiyoshi T. Technical feasibility of laparoscopic extended surgery beyond total mesorectal excision for primary or recurrent rectal
                   cancer. World J Gastroenterol 2016;22:718-26.
               62.  Nagayoshi K, Ueki T, Manabe T, Moriyama T, Yanai K, Oda Y, Tanaka M. Laparoscopic lateral pelvic lymph node dissection is
                   achievable and offers advantages as a minimally invasive surgery over the open approach. Surg Endosc 2016;30:1938-47.
               63.  Wichmann MW, Müller C, Meyer G, Strauss T, Hornung HM, Lau-Werner U, Angele MK, Schildberg FW. Effect of preoperative
                   radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 2002;137:206-10.
               64.  Kim YW, Kim NK, Min BS, Lee KY, Sohn SK, Cho CH, Kim H, Keum KC, Ahn JB. The prognostic impact of the number of lymph
                   nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol 2009;100:1-7.
               65.  Furuhata T, Okita K, Nishidate T, Ito T, Yamaguchi H, Ueki T, Akizuki E, Meguro M, Ogawa T, Kukita K, Kimura Y, Mizuguchi T,
                   Hirata K. Clinical feasibility of laparoscopic lateral pelvic lymph node dissection following total mesorectal excision for advanced
                   rectal cancer. Surg Today 2015;45:310-4.
               66.  Park JA, Choi GS, Park JS, Park SY. Initial clinical experience with robotic lateral pelvic lymph node dissection for advanced rectal
                   cancer. J Korean Soc Coloproctol 2012;28:265-70.
               67.  Bae SU, Saklani AP, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Robotic and laparoscopic pelvic lymph node dissection for rectal
                   cancer: short-term outcomes of 21 consecutive series. Ann Surg Treat Res 2014;86:76-82.
               68.  Kagawa H, Kinugasa Y, Shiomi A, Yamaguchi T, Tsukamoto S, Tomioka H, Yamakawa Y, Sato S. Robotic-assisted lateral lymph node
                   dissection for lower rectal cancer: short-term outcomes in 50 consecutive patients. Surg Endosc 2015;29:995-1000.
               69.  Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H. Robotic-assisted laparoscopic versus open lateral lymph node dissection
                   for advanced lower rectal cancer. Surg Endosc 2016;30:721-8.
               70.  Kim HJ, Choi GS, Park JS, Park SY, Lee HJ, Woo IT, Park IK. Selective lateral pelvic lymph node dissection: a comparative study of
                   the robotic versus laparoscopic approach. Surg Endosc 2018;32:2466-73.
               71.  Wiig JN, Waehre H, Larsen SG, Braendengen M, Giercksky KE. Radical prostatectomy for locally advanced primary or recurrent rectal
                   cancer. Eur J Surg Oncol 2003;29:455-8.
               72.  Saito N, Suzuki T, Sugito M, Ito M, Kobayashi A, Tanaka T, Kotaka M, Karaki H, Kobatake T, Tsunoda Y, Shiomi A, Yano M,
                   Minagawa N, Nishizawa Y. Bladder-sparing extended resection of locally advanced rectal cancer involving the prostate and seminal
                   vesicles. Surg Today 2007;37:845-52.
               73.  Smith JD, Nash GM, Weiser MR, Temple LK, Guillem JG, Paty PB. Multivisceral resections for rectal cancer. Br J Surg 2012;99:1137-43.
               74.  Shin US, You YN, Nguyen AT, Bednarski BK, Messick C, Maru DM, Dean EM, Nguyen ST, Hu CY, Chang GJ. Oncologic outcomes of
                   extended robotic resection for rectal cancer. Ann Surg Oncol 2016;23:2249-57.
               75.  Williams GL, Gonsalves S, Bandyopadhyay D, Sagar PM. Laparoscopic abdominosacral composite resection for locally advanced
   31   32   33   34   35   36   37   38   39   40   41